Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

June 2, 2024

Study Completion Date

June 2, 2024

Conditions
Upper Limb Spasticity
Interventions
BIOLOGICAL

ABBV-950

Intramuscular (IM) Injection

BIOLOGICAL

BOTOX

Intramuscular (IM) Injection

DRUG

Placebo for ABBV-950

Intramuscular (IM) Injection

Trial Locations (9)

20010

MedStar National Rehabilitation Hospital /ID# 255630, Washington D.C.

65212

University of Missouri Hospital /ID# 255310, Columbia

90242

Rancho Los Amigos National Rehabilitation center /ID# 255335, Downey

92011-4213

North County Neurology Associates /ID# 256333, Carlsbad

93710-5473

Neuro Pain Medical Center /ID# 256036, Fresno

06905

New England Institute for Clinical Research /ID# 255020, Stamford

33462-1141

JEM Research Institute /ID# 258782, Lake Worth

66211-1363

Kansas Institute of Research /ID# 254998, Overland Park

75235-7709

Ut Southwestern Medical Center /Parkland Health and Hospital System /Id# 255328, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY